Today's Focus:

tianqi lithium corporation (09696.HK) is expected to incur a loss of 0.32 billion to 0.64 billion yuan in the third quarter.

Tianqi Lithium Corporation (09696.HK) announced that for the 9 months ended September 30, 2024, (i) the estimated range of net loss attributable to shareholders of the company is expected to be between RMB 5,450 million and RMB 5,850 million (unaudited), while the net profit attributable to shareholders of the company in the same period last year was RMB 8,098.51 million; (ii) the estimated range of net loss after deducting non-recurring gains and losses is expected to be between RMB 5,470 million and RMB 5,870 million (unaudited), while the net profit after deducting non-recurring gains and losses in the same period last year was RMB 7,982.34 million; and (iii) the estimated range of basic loss per share is expected to be between RMB 3.32 and RMB 3.57 (compared to basic earnings per share of RMB 4.93 in the same period last year).

For the three months ended July 1 to September 30, 2024, the expected range of net loss attributable to the company's shareholders is estimated to be RMB 320 million to RMB 640 million (unaudited), while the net income attributable to the company's shareholders recorded by the group in the same period of the previous year was RMB 1,646.05 million; the expected range of net loss after deducting non-recurring gains and losses is estimated to be RMB 330 million to RMB 650 million (unaudited), while the net profit after deducting non-recurring gains and losses recorded by the group in the same period of the previous year was RMB 1,572.48 million; and the expected basic loss per share is estimated to be RMB 0.20 to RMB 0.39 (basic earnings per share for the same period of the previous year: RMB 1.00).

The board of directors believes that the main reasons for the performance changes in this reporting period are: 1. Due to the fluctuations in the lithium product market, from the fourth quarter of 2023 to the third quarter of 2024, the market price of lithium products overall showed a significant downward trend, resulting in a substantial decrease in the company's lithium product sales prices and gross profit compared to the same period of the previous year. Due to the mismatch between the pricing mechanism of chemical-grade lithium concentrate of the Company's controlling subsidiary Talison Lithium Pty Ltd and the pricing mechanism of the company's lithium chemical products, the company's operating performance has experienced periodic losses in this reporting period. In the first three quarters of 2024, the market price of chemical-grade lithium concentrate decreased, and the price of lithium concentrate newly purchased by Talison also decreased. With the gradual entry of newly purchased low-priced lithium concentrate into inventory and the gradual digestion of inventory lithium concentrate, the cost of chemical-grade lithium concentrate consumed in the production costs of various bases of the company is gradually approaching the latest purchase price. The phase mismatch of the lithium concentrate pricing mechanism is gradually weakening, and the losses in the second and third quarters of 2024 have both decreased compared to the previous quarter. At the same time, benefiting from the steady increase in production capacity of the newly established factories, the production and sales volume of lithium compounds and derivatives achieved year-on-year and quarter-on-quarter growth in the first three quarters of 2024 and the third quarter of 2024.

2. As of the date of this announcement, the Company's significant associated company Sociedad Química y Minera de Chile S.A. (SQM, a Chilean chemical and mining company) has not yet published its performance report for the third quarter of 2024. The Company has comprehensively considered the reliable information that can be obtained, adopted consistent methods, calculated the company's estimated investment income in SQM for the same period based on financial calculation models, and used information such as Bloomberg's forecast of SQM's earnings per share for the third quarter of 2024.

In addition, SQM announced in its first quarter performance report for 2024 that the Santiago Court in Chile ruled on the tax litigation for its 2017 and 2018 tax years in April 2024, overturning the conclusions of the tax and customs courts on November 7, 2022, resulting in the recognition of approximately USD 1.1 billion in income tax expenses and a corresponding reduction in net profit of approximately USD 1.1 billion.

Important event

shun tak hold (00242.HK) subsidiary entered into an agreement with Ocean Park Company to develop and operate an adventure-themed area.

Performance of Financial Report:

Sinopec SSC (01033.HK) achieved a net profit of 0.68 billion yuan in the first three quarters, a year-on-year increase of 52.4%.

jl mag rare-earth (06680.HK) net income in the first three quarters was 0.197 billion yuan, a 60.17% year-on-year decrease.

ch display opt (00334.HK) total revenue reached 2.941 billion yuan in the first three quarters, a year-on-year increase of 51.6%

Newborntown (09911.HK): Expected significant growth of approximately 60.7% to 62.7% in social business total revenue for the first three quarters.

Operation Data

china comm cons (01800.HK) newly signed contracts worth 1280.456 billion yuan in the first three quarters, an increase of 9.28% year-on-year.

Medical Innovation:

henlius (02696.HK): The international multicenter Phase 3 clinical study of the combination of Hansuzhu (serumulimumab injection) with bevacizumab injection and chemotherapy as first-line treatment for metastatic colorectal cancer (mCRC) has successfully dosed the first Japanese patient.

I-Mab-A-NG科-B(01541.HK): IMM0306 completed the first patient dosing in the phase IB clinical trial for treating systemic lupus erythematosus.

Acquisitions and Disposals:

elife hldgs (00223.HK): Chen Miaoping made a partial cash acquisition tender offer, will resume trading tomorrow.

sc holdings (00413.HK) plans to sell all the equity of Poben Consultants, Pok Lake Profits, and Tripstowe Management for 0.185 billion Hong Kong dollars.

qingdao hldgs (00499.HK) intends to publicly list for sale 95% equity of Huaiyi Construction, its subsidiary.

chi kingstone (01380.HK) may acquire the Pureo project's seven mining areas

Stock-Based Incentive:

Smoore Intl (06969.HK) granted a total of 66.9228 million bonus shares.

smoore intl (06969.HK) granted 93.4087 million share purchase rights.

Tianli International Holdings (01773.HK) granted a total of 9.4 million share options.

Repurchase cancellation.

alibaba-SW (09988.HK) spent $19.97 million on repurchasing 1.62 million shares on October 23.

Stanchart (02888.HK) spent 13.909 million pounds on October 23 to repurchase 1.638 million shares.

hsbc holdings (00005.HK) spent 68.1092 million Hong Kong dollars to repurchase 0.9892 million shares on October 23rd.

AIA (01299.HK) spent 61.885 million Hong Kong dollars on October 24 to repurchase 0.994 million shares.

Pru (02378.HK) spent 4.54 million British pounds on October 23 to repurchase 0.692 million shares.

Livzon Pharma (01513.HK) purchased 0.88 million shares of A shares on October 24th for a total of 32.8198 million yuan.

Yum China (09987.HK) spent 2.4 million US dollars on October 23 to repurchase 0.055 million shares.

Swire Pacific A (00019.HK) spent 12.545 million Hong Kong dollars on October 24 to repurchase 0.194 million shares.

Kuaishou-W (01024.HK) spent 12 million Hong Kong dollars on October 24 to repurchase 0.263 million shares.

Hygeia Health (06078.HK) spent 10.17 million Hong Kong dollars on October 24 to repurchase 0.5864 million shares.